United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2003_register
executive
2010-09-23
article
Drug Safety and Risk Management Advisory Committee; Notice of Postponement
Notices
D09002ee1bdeb7c50
D09002ee1bdeb7cc3
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) is postponing the meeting of the Drug Safety and Risk Management Advisory Committee scheduled for September 18, 2003, due to Hurricane Isabel. This meeting was announced in the Federal Register of June 30, 2003 (68 FR 38713). An amendment to the notice of meeting was announced in the Federal Register of July 23, 2003 (68 FR 43534). The future date for this meeting is to be determined.
68 FR 56845
https://www.govinfo.gov/app/details/FR-2003-10-02/03-24925
03-24925
fr02oc03-69
4160-01-S
https://www.govinfo.gov/app/details/FR-2003-10-02/03-24925
https://www.govinfo.gov/content/pkg/FR-2003-10-02/html/03-24925.htm
https://www.govinfo.gov/content/pkg/FR-2003-10-02/pdf/03-24925.pdf
2 p.
56845
56846
68 FR 56845
Drug Safety and Risk Management Advisory Committee; Notice of Postponement; Federal Register Vol. 68, Issue
NOTICE
03-24925
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
4160-01-S
03-24925
Notice.
The Food and Drug Administration (FDA) is postponing the meeting of the Drug Safety and Risk Management Advisory Committee scheduled for September 18, 2003, due to Hurricane Isabel. This meeting was announced in the Federal Register of June 30, 2003 (68 FR 38713). An amendment to the notice of meeting was announced in the Federal Register of July 23, 2003 (68 FR 43534). The future date for this meeting is to be determined.
Shalini Jain, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail: JAINS@CDER.FDA.GOV, or FDA Advisory Committee Information Line, 1-800- 741-8138 (301-443-0572 in the Washington, DC area), code 12535. Please call the Information Line for up-to-date information on this meeting.
Meetings:
Drug Safety and Risk Management Advisory Committee,
JAINS@CDER.FDA.GOV
Federal Register
Vol. 68, no. 191
Office of the Federal Register, National Archives and Records Administration
2003-10-02
continuing
daily
deposited
born digital
564 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2003-10-02
P0b002ee1809a001e
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr02oc03
https://www.govinfo.gov/app/details/FR-2003-10-02
https://www.govinfo.gov/content/pkg/FR-2003-10-02/pdf/FR-2003-10-02.pdf
https://www.govinfo.gov/content/pkg/FR-2003-10-02/xml/FR-2003-10-02.xml
fdlp
56765
56804
DGPO
2010-09-23
2023-05-04
FR-2003-10-02
machine generated
eng
FR
FR-2003-10-02
68
191